Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 48.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 18,942 shares of the company's stock after selling 17,898 shares during the period. Victory Capital Management Inc.'s holdings in Henry Schein were worth $1,381,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Cromwell Holdings LLC increased its position in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new stake in Henry Schein in the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA purchased a new position in Henry Schein in the second quarter valued at about $37,000. Blue Trust Inc. lifted its stake in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after purchasing an additional 346 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 0.6 %

Shares of HSIC traded up $0.44 during midday trading on Tuesday, hitting $77.28. The company had a trading volume of 2,207,672 shares, compared to its average volume of 1,403,080. The stock has a market cap of $9.64 billion, a price-to-earnings ratio of 31.80, a PEG ratio of 2.15 and a beta of 0.87. The company's 50 day moving average price is $71.03 and its 200 day moving average price is $69.76. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the company earned $1.32 earnings per share. Henry Schein's quarterly revenue was up .4% on a year-over-year basis. On average, equities research analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HSIC shares. Barrington Research reiterated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. JPMorgan Chase & Co. dropped their price objective on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research note on Monday, August 12th. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. UBS Group lowered their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Finally, StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $78.89.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. This represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.